BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36297411)

  • 1. Synthesis and Chemopreventive Potential of 5-FU/Genistein Hybrids on Colorectal Cancer Cells.
    Moreno-Quintero G; Castrillón-Lopez W; Herrera-Ramirez A; Yepes-Pérez AF; Quintero-Saumeth J; Cardona-Galeano W
    Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Hybrid Scaffolds Based on 5-FU/Curcumin: Synthesis, Cytotoxic, Antiproliferative and Pro-Apoptotic Effect.
    Moreno-Quintero G; Betancur-Zapata E; Herrera-Ramírez A; Cardona-Galeano W
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol/Hydrazone Hybrids: Synthesis and Chemopreventive Activity against Colorectal Cancer Cells.
    Castrillón-López W; Herrera-Ramírez A; Moreno-Quintero G; Coa JC; Naranjo TW; Cardona-Galeano W
    Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemopreventive Effect on Human Colon Adenocarcinoma Cells of Styrylquinolines: Synthesis, Cytotoxicity, Proapoptotic Effect and Molecular Docking Analysis.
    Bedoya-Betancur V; Correa E; Rendón JP; Yepes-Pérez AF; Cardona-Galeano W; Naranjo TW
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proapoptotic Effect and Molecular Docking Analysis of Curcumin-Resveratrol Hybrids in Colorectal Cancer Chemoprevention.
    Moreno-Q G; Herrera-R A; Yepes AF; Naranjo TW; Cardona-G W
    Molecules; 2022 May; 27(11):. PubMed ID: 35684424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Hybrids Based on Curcumin and Resveratrol: Synthesis, Cytotoxicity and Antiproliferative Activity against Colorectal Cancer Cells.
    Hernández C; Moreno G; Herrera-R A; Cardona-G W
    Molecules; 2021 May; 26(9):. PubMed ID: 34062841
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Herrera-R A; Moreno G; Araque P; Vásquez I; Naranjo E; Alzate F; Cardona-G W
    Iran J Pharm Res; 2021; 20(2):254-267. PubMed ID: 34567160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative Properties of 7,8-Ethylene Diamine Chelator-Lipophilic Fluoroquinolone Derivatives Against Colorectal Cancer Cell Lines.
    Khaleel S; Al-Hiari Y; Kasabri V; Haddadin R; Albashiti R; Al-Zweri M; Bustanji Y
    Anticancer Agents Med Chem; 2022; 22(5):1012-1028. PubMed ID: 34165411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Effects of Genistein In Vitro as a Chemopreventive Agent for Colorectal Cancer-Strategy to Improve Its Efficiency When Administered Orally.
    Rendón JP; Cañas AI; Correa E; Bedoya-Betancur V; Osorio M; Castro C; Naranjo TW
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attacking the mitochondria of colorectal carcinoma by novel 2-cyanoacrylamides linked to ethyl 1,3-diphenylpyrazole-4-carboxylates moiety as a new trend for chemotherapy.
    Mohamed MF; Saddiq AA; Abdelhamid IA
    Bioorg Chem; 2020 Oct; 103():104195. PubMed ID: 32896741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and
    Castrillón W; Herrera-R A; Prieto LJ; Conesa-Milián L; Carda M; Naranjo T; Maldonado ME; Cardona-G W
    Iran J Pharm Res; 2019; 18(4):1770-1789. PubMed ID: 32184845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Influence of 5-Fluorouracil on SMAD4 and TGFB1 Gene Expression, Apoptosis Induction and DNA Damage in Human Cell Lines.
    Wosiak A; Szmajda-Krygier D; Pietrzak J; Boncela J; Balcerczak E
    Bioengineering (Basel); 2023 May; 10(5):. PubMed ID: 37237640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antiproliferative agents bearing substituted thieno[2,3-d]pyrimidine scaffold as dual VEGFR-2 and BRAF kinases inhibitors and apoptosis inducers; design, synthesis and molecular docking.
    Hassan RA; Hamed MIA; Abdou AM; El-Dash Y
    Bioorg Chem; 2022 Aug; 125():105861. PubMed ID: 35569190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, cytotoxicity screening and molecular docking of new 3-cyanopyridines as survivin inhibitors and apoptosis inducers.
    Sabour R; Harras MF; Mehany ABM
    Bioorg Chem; 2020 Jan; 94():103358. PubMed ID: 31679838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents.
    Ahmed EY; Abdel Latif NA; El-Mansy MF; Elserwy WS; Abdelhafez OM
    Bioorg Med Chem; 2020 Mar; 28(5):115328. PubMed ID: 31992477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel pyrazolo[3,4-d]pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy.
    Ibrahim TS; Hawwas MM; Taher ES; Alhakamy NA; Alfaleh MA; Elagawany M; Elgendy B; Zayed GM; Mohamed MFA; Abdel-Samii ZK; Elshaier YAMM
    Bioorg Chem; 2020 Dec; 105():104352. PubMed ID: 33080494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo and In Vitro Enhanced Tumoricidal Effects of Metformin, Active Vitamin D
    Almaimani RA; Aslam A; Ahmad J; El-Readi MZ; El-Boshy ME; Abdelghany AH; Idris S; Alhadrami M; Althubiti M; Almasmoum HA; Ghaith MM; Elzubeir ME; Eid SY; Refaat B
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising Hybrids Derived from S-Allylcysteine and NSAIDs Fragments against Colorectal Cancer: Synthesis,
    Herrera-R A; Castrillón W; Pastrana M; Yepes AF; Cardona-G W
    Iran J Pharm Res; 2021; 20(3):351-367. PubMed ID: 34903994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rutamarin, an Active Constituent from
    Suhaimi SA; Hong SL; Abdul Malek SN
    Pharmacogn Mag; 2017 Jul; 13(Suppl 2):S179-S188. PubMed ID: 28808378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.